Suárez-Lledó Grande, María - Search Results - UAB Digital Repository of Documents

Search collections:

Sort by:	Display results:	Output format:

Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found

Articles	2 records found

14 p, 308.2 KB

At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation : A Unicentric, Safe, and Feasible Program / Ruiz-Boy, Sonia (Hospital Clínic i Provincial de Barcelona) ; Pedraza, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Prat, Marta (Hospital Clínic i Provincial de Barcelona) ; Salas, María Queralt (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Carcelero, Ester (Hospital Clínic i Provincial de Barcelona) ; Riu-Viladoms, G (Hospital Clínic i Provincial de Barcelona) ; Suárez-Lledó Grande, María (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Monge-Escartín, Inés (Hospital Clínic i Provincial de Barcelona) ; Rodríguez-Lobato, Luís Gerardo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martínez-Roca, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Rovira Argelagués, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martínez, Carmen (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gallego, Cristina (Hospital Clínic i Provincial de Barcelona) ; Urbano-Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sánchez, Juan (Hospital Clínic i Provincial de Barcelona) ; Marcos, María Ángeles (Hospital Clínic i Provincial de Barcelona) ; Fernández-Avilés, Francesc (Hospital Clínic i Provincial de Barcelona)
Cytomegalovirus (CMV) infection is a relevant cause of morbimortality in patients receiving allogeneic stem cell transplantation (allo-HCT). Foscarnet (FCN) is an effective drug against CMV administered intravenously and usually on an inpatient basis. [...]
2023 - DOI (Digital Object Identifier)

10.3390/ph16121741
Pharmaceuticals, Vol. 16 Núm. 12 (december 2023) , p. 1741

Detailed record -

10 p, 1.0 MB

Case report : Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders / Margarit-Soler, Adriana (Hospital Sant Joan de Déu (Manresa)) ; Deyà-Martínez, Ángela (Hospital Clínic i Provincial de Barcelona) ; Canizales, Juan Torres (Hospital Clínic i Provincial de Barcelona) ; Vlagea, Alexandru (Hospital Clínic i Provincial de Barcelona) ; García-García, Ana (Hospital Clínic i Provincial de Barcelona) ; Marsal, Júlia (Hospital Sant Joan de Déu (Manresa)) ; Trabazo del Castillo, María (Hospital Sant Joan de Déu (Manresa)) ; Planas, Sílvia (Hospital Sant Joan de Déu (Manresa)) ; Simó, Sílvia (Hospital Sant Joan de Déu (Manresa)) ; Esteve-Sole, Ana (Hospital Clínic i Provincial de Barcelona) ; Suárez-Lledó Grande, María (Hospital Clínic i Provincial de Barcelona) ; Badell Serra, Isabel (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Rovira Tarrats, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Fernandez Aviles, Francesc (Hospital Clínic i Provincial de Barcelona) ; Alsina Manrique, Laia (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) haploinsufficiency is a T-cell hyperactivation disorder that can manifest with both immunodeficiency and immune dysregulation. Approximately one-third of patients may present mild symptoms and remain stable under supportive care. [...]
2022 - DOI (Digital Object Identifier)

10.3389/fimmu.2022.1070068
Frontiers in immunology, Vol. 13 (december 2022)

Detailed record -

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.